2022
-
GSK Pharma bets on growing adult vaccine market 10 December 2022
Source : The Times of India
British drug firm is betting on power brands, innovative launches in adult vaccines, and a strong recovery in pediatric immunization, to grow double-digit in its key emerging market, India.
-
GSK's pharma brands doing well: India MD 03 September 2022
Source : The Economic Times
GlaxoSmithKline Pharmaceuticals, the Indian unit of the UK's GSK, said its top medicine brands, including Augmentin, Calpol and Supacef, are holding on to their market shares, and the recent price increase and partial stabilisation of raw material prices will help it maintain operating margins in FY23...
-
From childhood to adulthood: The need for life course vaccination 29 April 2022
Source : The Times of India
For most of us, the word 'vaccination' is synonymous with paediatric vaccination and conjures up images of a crying baby, concerned parents, a genial doctor, and multiple injections...
-
GSK launches once daily, single inhaler-triple therapy for COPD patients 26 April 2022
Source : The Economic Times
GlaxoSmithKline Pharmaceuticals on Tuesday said it has launched Trelegy Ellipta for Chronic Obstructive Pulmonary Disease (COPD) patients...
-
GSK launches single-inhaler triple therapy in India for COPD patients 26 April 2022
Source : Financial Express
GlaxoSmithKline (GSK) Pharmaceuticals Limited has launched the first single-inhaler triple therapy (SITT) in India for Chronic Obstructive Pulmonary Disease (COPD) patients...
-
GSK and MS Dhoni team up for 6-in-1 vaccination awareness campaign 24 February 2022
Source : ETBrandEquity
The campaign for the '6 in 1' vaccination consists of a website and an ad-film that will run across multiple formats including TV and YouTube...
-
GSK Pharma India chief on pandemic decisions, refreshing the portfolio 28 January 2022
Source : Scrip
GSK India managing director Sridhar Venkatesh outlines how the company navigated pandemic-related turbulence and “stuck its neck out” to ensure uninterrupted supplies of key drugs...
Archive
2021
Economic Times HealthWorld, 25/09/2021
Severe Asthma: The Implications and Effective Management
Economic Times HealthWorld, 05/05/2021
GSK Pharma India’s Dr. Markandeywar, Dr. Sharma and Dr. Gvalani uncover asthma misconceptions
2020
The Economic Times, 15/10/2020
The pandemic fast forwarded our digital journey: Sridhar Venkatesh, Managing Director, India, GSK Pharmaceuticals
The Economic Times, 01/10/2020
There is a greater need now for quick results without any compromise on efficacy and patient safety : Sridhar Venkatesh, Managing Director, GSK India
Reuters, 20/06/2020
GSK in quest to be best, not first, in race for COVID-19 vaccine
CNBC TV 18, 10/06/2020
When can we expect a COVID-19 vaccine?
2018
Business Standard, 13/06/2018
